Delivery Order SPE2DB20D9103-SPE2DB25FE7D7
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, received a delivery order award from the Defense Logistics Agency (DLA) on September 18, 2025, for Primaquine 26.3 mg tablets (100-count units) valued at $2,345.08. This firm fixed-price delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $499.999 billion vehicle that enables the agency to procure a comprehensive range of...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Primaquine 26.3 mg tablets (quantity 28). This firm fixed-price delivery order, valued at $2,091.04, carries an ultimate completion date of September 2, 2025, and was awarded on August 11, 2025, with no set-aside designation applied. The order falls under DMS Pharmaceutical Group's larger single-award...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $56,010.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Primaquine 26.3 mg tablets in quantities of 28 units. This firm fixed-price delivery order, issued on July 14, 2025, carries an ultimate completion date of August 4, 2025, and represents no set-aside designation. The award was issued under DMS Pharmaceutical Group's existing...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 100 tablets of Primaquine 26.3 mg. The contract, valued at $2,322.40 with an ultimate completion date of September 5, 2025, was issued without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at $499.999...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,873.72, is for the delivery of 14-count packs of 26.3 mg Primaquine tablets. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The...
- The Defense Logistics Agency awarded a delivery order valued at $55,680 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Primaquine 26.3 mg tablets in quantities of 28 units. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and was executed on August 21, 2025. This award carries no set-aside designation, allowing the vendor to compete...
- The Defense Logistics Agency awarded a delivery order valued at $2,165.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Primaquine 26.3 mg tablets (28-count packaging). This firm fixed-price delivery order, issued on July 28, 2025, is scheduled for ultimate completion by August 18, 2025, with performance taking place at the vendor's Park Ridge facility. The award carries no set-aside designation, allowing...
- This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,697.92 firm fixed price delivery order is for the supply of Primaquine 26.3 mg tablets. It is not associated with a set-aside program. DMS Pharmaceutical Group Inc. holds a single-award indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $93,550.00 contract is for the delivery of 4554877999 - Primaquine 26.3 mg Tablets (28s) to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,120.20 contract is for the delivery of Primaquine 26.3 mg tablets to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at up to $499,999,999, which allows the...
- SPE2DB20D9103Indefinite Delivery Contract
- SPE2DB20D9103-SPE2DB25FE7D7Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,435.28 by the Defense Logistics Agency (DLA) on August 6, 2025. The contract, with an ultimate completion date of August 27, 2025, covers the supply of Primaquine 26.3 mg tablets in quantities of 28 units. This delivery order was issued without a set-aside designation and represents work performed under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at $499,999,999 and remains valid through November 2026. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering medications and medical supplies to Department of Defense healthcare facilities nationwide. Primaquine, an antimalarial medication, is among the diverse pharmaceutical portfolio the company provides through its DLA contract vehicle, which encompasses branded and generic prescription drugs, biologics, and medical consumables. The company's performance under this delivery order supports the DLA's mission to supply pharmaceutical products to military health facilities globally, leveraging its woman-owned small business status and two decades of federal contracting experience.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 8/6/25 |